The prognosis of patients with primary and secondary liver tumors has improved over the past decade due to refined surgical approaches, new systemic treatment options and irradiaton techniques and not last continous development and improvement of diagnotic tools. In addition to these well-established treatment modalities, there is an increasing use of interventional therapies directly targeting liver malignancies with curative and palliative intent.
The question “when and whom” to treat with an interventional treatment modality is again the focus of the 3rd ITLT which will take place in Essen, Germany and can only be answered within the framework of a close interdisciplinary cooperation.
During this conference a panel of internationally well renowned experts will outline the state of the art of different treatment modalities of liver malignancies such as hepatocellular and cholangiocellular carcinoma as well as liver metastases of other primaries. They will discuss the various treatment options and try to put them into a rationally based perspective.
We cordially invite you to attend this meeting and encourage you to participate actively by submitting an abstract focusing on multidisciplinary treatment or interventional oncology in liver malignancies considered for oral or poster presentation.
We are expecting an outstanding symposium and looking forward to meet you in Essen.
Prof. Dr. Hansjochen Wilke